The pharmacolgy of 5-(2-t-butylamino-1-hydroxyethyl) salicylamide (ah 3474), a beta-adrenoreceptor blocking agent.
D000772:Anesthesia, Local; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004285:Dogs; D005260:Female; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008297:Male; D010042:Ouabain / Q000037:antagonists & inhibitors; D051381:Rats; D012457:Salicylamides / Q000494:pharmacology*; D013565:Sympatholytics / Q000494:pharmacology* / Q000633:toxicity; D014599:Uterus / Q000187:drug effects
D012457:Salicylamides; D013565:Sympatholytics; D010042:Ouabain; D007545:Isoproterenol